Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Intangibles (2016 - 2026)

Mimedx's Intangibles history spans 17 years, with the latest figure at $13.1 million for Q1 2026.

  • On a quarterly basis, Intangibles rose 18.79% to $13.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $13.1 million, a 18.79% increase, with the full-year FY2025 number at $14.2 million, up 21.78% from a year prior.
  • Intangibles hit $13.1 million in Q1 2026 for Mimedx, down from $14.2 million in the prior quarter.
  • Over the last five years, Intangibles for MDXG hit a ceiling of $14.2 million in Q4 2025 and a floor of $5.0 million in Q3 2022.
  • Historically, Intangibles has averaged $8.9 million across 5 years, with a median of $11.1 million in 2025.
  • Biggest five-year swings in Intangibles: skyrocketed 121.15% in 2024 and later fell 11.86% in 2025.
  • Tracing MDXG's Intangibles over 5 years: stood at $5.9 million in 2022, then dropped by 10.17% to $5.3 million in 2023, then surged by 121.15% to $11.6 million in 2024, then rose by 21.78% to $14.2 million in 2025, then decreased by 7.19% to $13.1 million in 2026.
  • Business Quant data shows Intangibles for MDXG at $13.1 million in Q1 2026, $14.2 million in Q4 2025, and $11.1 million in Q3 2025.